The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.
Topic Healthy Subjects
Country United States of America
Visit trial
Status
Unknown status
Results Published
Start date
01 October 2019
End date
01 October 2020
Chance of happening
0%
Phase
Phase I
Design
Blinded
Type
Interventional
Generation
First
Participants
26
Sex
All
Age
18- 65
Therapy
No
Trial Details
This is a pilot project using dcEEG to look at infra-slow waves in depressed patients receiving ECT randomized to ketamine or methohexital where ketamine suppresses infra-slow waves. The rationale for this project is to identify biomarkers of treatment adequacy in ECT, which could lead to decreased morbidity and mortality with the procedure and lessen the burden of depression in our patient population.NCT Number NCT04022226
Sponsors & Collaborators
University of OttawaThe University of Ottawa launched The Psychedelics & Spirituality Studies Initiative (PSSI) in 2021. PSSI is an interdisciplinary group of faculty and graduate students who share a common interest in the study of psychedelics, spirituality and integrative healing.
McGill University
Psychedelic research is well underway at McGill University. At the Neurobiological Psychiatry Unit, researchers are assessing the effects of psychedelics at the behavioral, brain circuit, neuronal, and subcellular levels.
Queen's University
This company doesn't have a full profile yet, it is linked to a clinical trial.